In yesterday’s Wall Street session, Ambev S.A. ADR (NYSE:ABEV) shares traded at $2.30, up 0.44% from the previous session.
ABEV stock price is now 1.29% away from the 50-day moving average and 0.28% away from the 200-day moving average. The market capitalization of the company currently stands at $36.17B.
With the price target reduced from $3.50 to $3, Barclays Downgraded its rating from Overweight to Equal Weight for Ambev S.A. ADR (NYSE: ABEV). , while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
A total of 0.00% of the company’s stock is owned by insiders.
During the past 12 months, Ambev S.A. ADR has had a low of $2.01 and a high of $2.85. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 1.20, and a quick ratio of 0.89. According to the stock market information, the enterprise value for the company is $19359727616, which is based on a 13.40 price-to-earnings ratio, a 7.08 price-to-earnings-growth ratio, and a beta of 1.06. The fifty day moving average price for ABEV is $2.2728 and a two-hundred day moving average price translates $2.2948 for the stock.
The latest earnings results from Ambev S.A. ADR (NYSE: ABEV) was released for 2024-09-30. The net profit margin was 17.02% and return on equity was 15.07% for ABEV. The company reported revenue of $3.98 billion for the quarter, compared to $4.16 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.25 percent. For the current quarter, analysts expect ABEV to generate $24.74B in revenue.
